Care TransitionsNCT03683797
Testing the Efficacy of a Post-discharge Call Program on the Rate of Readmission
A study testing Post-discharge call in people with Care Transitions, run by NYU Langone Health at 1 site in United States.
Trial summary
NYU Langone Health patients receive a call from a clinical care coordinator after they are discharged from the hospital (within 1-3 days). The current study is testing the efficacy of this program. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Care Transitions
- What is being tested?
- Post-discharge call
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 3,267 participants
- Where
- 1 siteUnited States
- Study dates
- 13 Aug 2018to 22 Mar 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- All patients discharged from NYU Langone Health who are eligible to receive a call from a clinical care coordinator after they were discharged from the hospital.
Who cannot join
- N/A
Trial locations and contacts
1 site in 1 country.
United States1 site
New York University School of Medicine
New York, New York, 10016
About this study
NYU Langone Health patients receive a call from a clinical care coordinator after they are discharged from the hospital (within 1-3 days). The current study is testing the efficacy of this program.
- Conditions
- Care Transitions
- Being tested
- Post-discharge call
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Post-discharge callOther
Patients will receive a call 1-3 days after they were discharged from the hospital to make sure their healthcare needs are being met.
| Study group | Role | What they receive |
|---|---|---|
| Post-discharge call | Experimental | Patients in this arm will receive a call from a clinical care coordinator after they have been discharged from NYU Langone Health. Receives: Other: Post-discharge call |
| No post-discharge call | No intervention | Patients in this arm will not receive a call from a clinical care coordinator after they have been discharged from NYU Langone Health. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of readmission
Number of patients admitted to a hospital within after being discharged from an earlier hospital stay.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Sep 2018
- Study start13 Aug 2018
- Primary completion30 Nov 2018
- Study completion22 Mar 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Care TransitionsStudies of the same condition, open and under way.
- More trials run by NYU Langone HealthThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 3,267 participants (actual)
Sponsor and investigators
- Lead sponsor
- NYU Langone Health
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Leora Horwitz, MD, MHS, Principal investigator, NYU Langone Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03683797
- Sponsor's protocol ID
- RCT post-discharge calls
- Status last verified
- Jul 2021
- First submitted
- 28 Aug 2018
- Last updated
- 20 Jul 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Jul 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Testing the Efficacy of a Post-discharge Call Program on the Rate of Readmission
- ClinicalTrials.gov ID
- NCT03683797
- Acronym / sponsor ID
- RCT post-discharge calls
- Conditions
- Care Transitions
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 3,267 participants (actual)
- Lead sponsor
- NYU Langone HealthUniversity, hospital or other
- Study start
- 13 Aug 2018 (actual)
- Primary completion
- 30 Nov 2018 (actual)
- Study completion
- 22 Mar 2019 (actual)
- First posted
- 25 Sep 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
NYU Langone Health patients receive a call from a clinical care coordinator after they are discharged from the hospital (within 1-3 days). The current study is testing the efficacy of this program.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Post-discharge call | Experimental | Other: Post-discharge callPatients in this arm will receive a call from a clinical care coordinator after they have been discharged from NYU Langone Health. |
| No post-discharge call | No intervention | –Patients in this arm will not receive a call from a clinical care coordinator after they have been discharged from NYU Langone Health. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- All patients discharged from NYU Langone Health who are eligible to receive a call from a clinical care coordinator after they were discharged from the hospital.
Key exclusion criteria (1 listed)
- N/A
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Post-discharge callPatients will receive a call 1-3 days after they were discharged from the hospital to make sure their healthcare needs are being met. | Other | Post-discharge call |
Primary outcome
Rate of readmission
Time frame: 6 months
Number of patients admitted to a hospital within after being discharged from an earlier hospital stay.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Jul 2021.
Related trials for Care Transitions
Not yet recruiting
Optimizing Care Transitions in CHD
Congenital Heart Disease (CHD), Mentorship
Active, not recruiting
Diabetes Toolkit at Discharge
Diabetes Mellitus, Type 2, Insulin Dependent Diabetes
Recruiting
I-SLEPT: Integrated Sleep and Life Engagement Program for Transitions
Sleep, Participation
Not yet recruiting
Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring
Type 2 Diabetes
Active, not recruiting
Celiac Disease in Childhood-Adulthood Transition
Celiac Disease, Celiac Disease in Children
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Leora Horwitz, MD, MHS principal investigator
NYU Langone Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Post-discharge call in people with Care Transitions, run by NYU Langone Health at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of readmission (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2021.